Description: Preface. I: The New Faces in Epidemiology. 1. Epidemiology of Inflammatory Bowel Disease in the North of Portugal; F. Tavarela Veloso. 2. Epidemiology of Inflammatory Bowel Disease in the South of Portugal; E. Monteiro, J. Freitas, C. Soares, P. Martins, F. Cunha Leal, M. Dupont, P. Borralho, A. Baptista. 3. Epidemiology of Inflammatory Bowel Disease in Vigo Health Area, Spain; V. Ruiz Ochoa, M. Butrn, S. Pereira, D. Rodriguez, J. Clofent, I. Otero, J.R. Pineda. 4. Epidemiology of Inflammatory Bowel Disease in Italy; P.A. Biandi, P. Bodini, A. Zambelli, M. Curzio, T. Ranzi. 5. Inflammatory Bowel Disease in Norway, with special emphasis on the incidence study of South Eastern Norway from 1990, initiated in collaboration with the European Community--IBD Study Group; M.H. Vatn, B. Moum, the IBSEN Study Group of Specialists. II: New Elements in Inflammation Basis for Future Treatments. 6. Annual models, importance of therapeutic strategies; E.P. Van Rees, M.J.H.J. Palmen, L.A. Dieleman, S.G.M. Meuwissen, A.S. Pea. 7. Oxidants, free radicals and Inflammatory Bowel Disease; M.B. Grisham, S. Aiko. 8. Role of nitric oxide in the pathogenesis of IBD; D. Rachmilewitz, J.S. Stamler, F. Karmeli, J. Loscalzo, R.J. Xavier, D.K. Xavier, D.K. Podolsky. 9. Failed redox control as a cause of ulcerative colitis; W.E.W. Roediger. III: The Battle of IBD Pathogenesis -- Is There a Winner? 10. The contribution of medical genetics to the understanding of the predisposition of ulcerative colitis and Crohn's disease; A.S. Pea, J.B.A. Crusius, M. Oudkerk Pool, G. Bouma, G. Bioque, S.G.M. Meuwissen. 11. Environmental factors -- Bacterial factors; J.D. Sanderson. 12. Advances in the understanding of the pathophysiology of IBD; D.K. Podolsky. IV: Diagnosis of IBD, New and Old Techniques. 13. The role of colonoscopy in Inflammatory Bowel Disease; M. Canto, M.V. Sivak Jr. 14. Nuclear Medicine techniques in Inflammatory Bowel Disease; H.J.F. Hodgson. 15. Ultrasonography in the diagnosis of Inflammatory Bowel Disease; W.B. Schwerk. V: Controversies in Clinical Management. 16. Inflammatory Bowel Disease and irritable bowel syndrome: similar symptoms, different treatments? S.F. Phillips. 17. Cancer risk in Ulcerative Colitis; R.N. Allan. 18. Colorectal cancer mortality in Inflammatory Bowel Disease: How can we best prevent it? B.A. Lashner. 19. Laboratory parameters -- How relevant are they? C. Prantera, F. Zannoni. VI: New Insights in Therapy. 20. The new aminosalicylates; M. Campieri, P. Gionchetti, M. Ferreti, A. Belluzzi, F. Rizzello, A. Venturi, C. Brignoli, M. Miglioli, L. Barbara. 21. Studies on oral budesonide in Crohn's disease; J. Scholmerich, K. Ewe, V. Gross. 22. Immunosuppressive therapy: Methotrexate and Cyclosporine; D.H. Present. 23. Rationale and experience with FR 506 in the treatment of Inflammatory Bowel Disease; D.H. Van Thiel, S. Faginoli, P. Caraceni, P. Carroll, S.R. Deal, J.S. Gavaler. 24. Nutrition -- Enteral or parenteral; M.E. Camilo. 25. Medical treatment of Chronic Inflammatory Bowel Diseases; L. Demling. VII: Difficult Decisions in IBD. 26. Extraintestinal manifestations. A personal approach; F. Tavarelo Veloso. 27. Fistulating Crohn's Disease; M. Irving. 28. Pouchitis -- What is the best management? G. Hellers. 29. Prognostic factors in an accute attack of severe Ulcerative Colitis, the value of barium enema examination after the first week of intensive medical treatment; L.A.R. Boerr, A.M. Sambuelli, J.C. Bai, A. Grazziano, J. Valero, Z. Kogan. 30. Inflammatory Bowel Disease: A look into the future; C. Fiocchi.

Please Wait